CAN
HQL

Claraphi Advisory Network’s abrdn Life Sciences Investors HQL Stock Holding History

Claraphi Advisory Network’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,146
Closed -$319K – 321
2020
Q4 		$319K Buy
16,146
+1,528
+10% +$28.2K 0.09% 200
2020
Q3 		$257K Buy
14,618
+519
+4% +$9.29K 0.09% 189
2020
Q2 		$253K Buy
14,099
+10,332
+274% +$177K 0.11% 190
2020
Q1 		$56K Buy
+3,767
New +$61.7K 0.03% 447
2019
Q4 		– Sell
-10,039
Closed -$152K – 281
2019
Q3 		$152K Sell
10,039
-27,210
-73% -$436K 0.09% 222
2019
Q2 		$628K Sell
37,249
-2,013
-5% -$33.2K 0.37% 61
2019
Q1 		$673K Sell
39,262
-23,092
-37% -$399K 0.42% 50
2018
Q4 		$942K Sell
62,354
-4,280
-6% -$75.4K 0.72% 28
2018
Q3 		$1.36M Buy
66,634
+4,765
+8% +$94.8K 0.76% 25
2018
Q2 		$1.16M Sell
61,869
-140,499
-69% -$2.64M 0.75% 29
2018
Q1 		$3.89M Sell
202,368
-14,990
-7% -$300K 2.76% 3
2017
Q4 		$4.27M Buy
+217,358
New +$4.35M 3.31% 3

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Claraphi Advisory Network's HQL Position: Q1 2021 in Review

Claraphi Advisory Network sold out of abrdn Life Sciences Investors (HQL) in Q1 2021, closing a stake of 16,146 shares — an estimated $319K sold.

Claraphi Advisory Network first reported a position in HQL in Q4 2017 and held it in 12 quarters. The position peaked at $4.27M in Q4 2017. 65 funds tracked by Wall St. Rank hold HQL as of Q1 2021.

  • Claraphi Advisory Network reported no remaining abrdn Life Sciences Investors position as of Q1 2021 after selling out during the quarter.
  • Claraphi Advisory Network sold 16,146 abrdn Life Sciences Investors shares in Q1 2021, an estimated $319K.
  • Claraphi Advisory Network first reported a position in abrdn Life Sciences Investors in Q4 2017 and held it in 12 quarters.
  • Claraphi Advisory Network's abrdn Life Sciences Investors position peaked at $4.27M in Q4 2017.
  • 65 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2021.

Based on Claraphi Advisory Network's 13F filing for Q1 2021, filed 30 Apr 2021.